Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer

Y. J. Park; E. H. Koh; J. Kim; J. K. Roh; J. Chang; C. M. Ahn; H. Y. Sohn; W. Y. Lee; K. Kim; C. O. Suh; G. E. Kim; J. J.K. Loh; B. S. Kim

doi:10.3349/ymj.1989.30.1.30

Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer

Y. J. Park, E. H. Koh, J. Kim, J. K. Roh, J. Chang, C. M. Ahn, H. Y. Sohn, W. Y. Lee, K. Kim, C. O. Suh, G. E. Kim, J. J.K. Loh, B. S. Kim

Department of Radiation Oncology

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	30-37
Number of pages	8
Journal	Yonsei medical journal
Volume	30
Issue number	1
DOIs	https://doi.org/10.3349/ymj.1989.30.1.30
Publication status	Published - 1989

All Science Journal Classification (ASJC) codes

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3349/ymj.1989.30.1.30

Cite this

Park, Y. J., Koh, E. H., Kim, J., Roh, J. K., Chang, J., Ahn, C. M., Sohn, H. Y., Lee, W. Y., Kim, K., Suh, C. O., Kim, G. E., Loh, J. J. K., & Kim, B. S. (1989). Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer. Yonsei medical journal, 30(1), 30-37. https://doi.org/10.3349/ymj.1989.30.1.30

@article{f9ee66a889e44eb8aaf43a0976ccb1f6,

title = "Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer",

author = "Park, {Y. J.} and Koh, {E. H.} and J. Kim and Roh, {J. K.} and J. Chang and Ahn, {C. M.} and Sohn, {H. Y.} and Lee, {W. Y.} and K. Kim and Suh, {C. O.} and Kim, {G. E.} and Loh, {J. J.K.} and Kim, {B. S.}",

year = "1989",

doi = "10.3349/ymj.1989.30.1.30",

language = "English",

volume = "30",

pages = "30--37",

journal = "Yonsei medical journal",

issn = "0513-5796",

publisher = "Yonsei University College of Medicine",

number = "1",

}

Park, YJ, Koh, EH, Kim, J, Roh, JK, Chang, J, Ahn, CM, Sohn, HY, Lee, WY, Kim, K, Suh, CO, Kim, GE, Loh, JJK & Kim, BS 1989, 'Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer', Yonsei medical journal, vol. 30, no. 1, pp. 30-37. https://doi.org/10.3349/ymj.1989.30.1.30

TY - JOUR

T1 - Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer

AU - Park, Y. J.

AU - Koh, E. H.

AU - Kim, J.

AU - Roh, J. K.

AU - Chang, J.

AU - Ahn, C. M.

AU - Sohn, H. Y.

AU - Lee, W. Y.

AU - Kim, K.

AU - Suh, C. O.

AU - Kim, G. E.

AU - Loh, J. J.K.

AU - Kim, B. S.

PY - 1989

Y1 - 1989

UR - http://www.scopus.com/inward/record.url?scp=0024539937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024539937&partnerID=8YFLogxK

U2 - 10.3349/ymj.1989.30.1.30

DO - 10.3349/ymj.1989.30.1.30

M3 - Article

C2 - 2545051

AN - SCOPUS:0024539937

SN - 0513-5796

VL - 30

SP - 30

EP - 37

JO - Yonsei medical journal

JF - Yonsei medical journal

IS - 1

ER -

Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this